Clinical Trial

Digital Application for Stroke Health

Study acronym: DASH
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Stroke is a leading cause of death and long-term disability worldwide. Despite substantial advances in acute stroke care, there remains a lack of evidence-based digital solutions to support patients after hospital discharge. This study evaluates the effectiveness of a digital health application (StrokeApp) designed to support patients with ischemic or hemorrhagic stroke or transient ischemic attack (TIA) in secondary prevention and recovery. In this multicenter, randomized, controlled, open-label trial, 500 patients will be assigned in a 1:1 ratio to receive either standard care alone or standard care in combination with StrokeApp. The primary objective is to assess the impact of the application on health-related quality of life three months after discharge. Secondary and exploratory outcomes include health literacy, medication adherence, vascular risk factors, health-related behaviors, psychosocial outcomes, long-term recovery up to twelve months, as well as safety and user experience.
Trial Details
NCT Number NCT07511868
Lead Sponsor VASCage GmbH
Collaborators: Medical University Innsbruck, Evaluation Software Development (ESD)
Conditions Haemorrhagic Stroke, Ischaemic Stroke, Transient Ischemic Attack (TIA)
Enrollment 500 participants
Start Date 2026-04-01
Primary Completion 2026-12-31 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-04-06